Literature DB >> 1893619

Tumour necrosis factor/cachectin plays a key role in autoimmune pulmonary inflammation in lupus-prone mice.

Y Deguchi1, S Kishimoto.   

Abstract

The role of tumour necrosis factor-alpha (TNF-alpha) in the development of autoimmune pulmonary inflammation has been investigated in lupus-prone mice. An increase in TNF-alpha mRNA level from whole lung preparation of lupus-prone mice was evident, from 3 weeks to 12 weeks during growing process, as shown by Northern blot analysis, but not in control mice. Furthermore, it is also found that the major source of this increase in TNF-alpha mRNA was attributed to infiltrating mononuclear cells found within the lung. Treatment of lupus-prone mice with rabbit anti-mouse TNF-alpha IgG prevented the development of pulmonary inflammation lesions such as lung fibrosis and alveolitis. These results suggest that an increased TNF-alpha production by infiltrating mononuclear cells in the lungs of lupus-prone mice may play a role in the development of autoimmune pulmonary inflammation and in significant changes of cytokines and the immune responses in pulmonary inflammation lesions of lupus-prone mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893619      PMCID: PMC1535595          DOI: 10.1111/j.1365-2249.1991.tb05737.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

Review 1.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.

Authors:  J C Reed; Y Tsujimoto; J D Alpers; C M Croce; P C Nowell
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

Review 4.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

5.  Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation.

Authors:  G E Grau; V Kindler; P F Piguet; P H Lambert; P Vassalli
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

6.  Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice. Model for human vasculitis in connective tissue disease.

Authors:  E L Alexander; C Moyer; G S Travlos; J B Roths; E D Murphy
Journal:  Arthritis Rheum       Date:  1985-10

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Protooncogene expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus as an indicator of the disease activity.

Authors:  Y Deguchi; H Hara; S Negoro; T Kakunaga; S Kishimoto
Journal:  Clin Immunol Immunopathol       Date:  1987-12

9.  Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities.

Authors:  J H Berden; L Hang; P J McConahey; F J Dixon
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

10.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.

Authors:  K J Tracey; H Wei; K R Manogue; Y Fong; D G Hesse; H T Nguyen; G C Kuo; B Beutler; R S Cotran; A Cerami
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Tumour necrosis factor and other cytokines in murine lupus.

Authors:  A N Theofilopoulos; B R Lawson
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Fluorescent light activates the immunomodulator cis-urocanic acid in vitro: implications for patients with systemic lupus erythematosus.

Authors:  H McGrath; J M Bell; J W Haycock
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

Review 4.  Anti-TNF-alpha therapies in systemic lupus erythematosus.

Authors:  Lang-Jing Zhu; Xiao Yang; Xue-Qing Yu
Journal:  J Biomed Biotechnol       Date:  2010-06-22

Review 5.  Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.

Authors:  Desmond Yat Hin Yap; Kar Neng Lai
Journal:  J Biomed Biotechnol       Date:  2010-05-06

6.  Suppression of pulmonary injury in experimental 'Goodpasture's syndrome' by deoxyspergualin (DSP).

Authors:  H Y Lan; D J Nikolic-Paterson; M Zarama; P G Kerr; R C Atkins
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

Review 7.  The role of cytokine in the lupus nephritis.

Authors:  Yasunori Iwata; Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  J Biomed Biotechnol       Date:  2011-10-18

8.  Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus.

Authors:  Maciej Lech; Christoph Römmele; Onkar P Kulkarni; Heni Eka Susanti; Adriana Migliorini; Cecilia Garlanda; Alberto Mantovani; Hans-Joachim Anders
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

9.  SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus.

Authors:  Martin Aringer; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2003-05-14       Impact factor: 5.156

Review 10.  The role of tumor necrosis factor-alpha in systemic lupus erythematosus.

Authors:  Martin Aringer; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2008-01-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.